{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:01:15Z","timestamp":1780081275057,"version":"3.54.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Polycystic ovary syndrome (PCOS) is often accompanied by increased oxidative stress levels; however, it is still unclear whether PCOS itself is causally related to oxidative stress (OS), whether OS can increase the occurrence of PCOS, and which characteristics of PCOS increase OS levels. Therefore, this study explored the causal relationship between PCOS, its characteristics, and OS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Two-sample bidirectional and two-sample Mendelian randomisation studies were performed based on publicly available statistics from genome-wide association studies. PCOS; its characteristics, such as testosterone, low-density lipoprotein, high-density lipoprotein; and 11 major OS markers (superoxide dismutase, glutathione S-transferase, glutathione peroxidase, catalase, uric acid, zinc, tocopherol, ascorbic acid, retinol, albumin, and total bilirubin), were studied. The main analytical method used was inverse variance weighting (IVW). Pleiotropy was evaluated using the Mendelian randomisation-Egger intercept. Q and P values were used to assess heterogeneity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There was no causal relationship between PCOS and the OS indices (all P\u2009&gt;\u20090.05). There was a causal relationship between the OS index, ascorbate level, and PCOS (IVW, odds ratio: 2.112, 95% confidence interval: 1.257\u20133.549, P\u2009=\u20090.005). In addition, there was a causal relationship between testosterone, low-density lipoprotein, high-density lipoprotein, sex hormone-binding globulin, body mass index, triacylglycerol, age at menarche, and most OS indices according to the IVW method. The F statistics showed that there was no weak instrumental variable. A sensitivity analysis was performed using the leave-one-out method. No pleiotropy was observed. The results were robust, and the conclusions were reliable.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study showed for the first time that there was no causal relationship between PCOS and OS. However, there was a causal relationship between the OS index, ascorbate level, and PCOS. It revealed that PCOS itself could not increase OS, and the increase in OS in PCOS was related to other potential factors, such as testosterone, low-density lipoprotein, high-density lipoprotein, sex hormone-binding globulin, body mass index, triacylglycerol, and age at menarche.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12920-023-01581-0","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T09:02:14Z","timestamp":1687165334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Evidence for causal effects of polycystic ovary syndrome on oxidative stress: a two-sample mendelian randomisation study"],"prefix":"10.1186","volume":"16","author":[{"given":"Pu","family":"Yifu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,19]]},"reference":[{"issue":"3","key":"1581_CR1","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/humupd\/dms059","volume":"19","author":"M Murri","year":"2013","unstructured":"Murri M, Luque-Ramirez M, Insenser M, Ojeda-Ojeda M, Escobar-Morreale HF. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update. 2013;19(3):268\u201388.","journal-title":"Hum Reprod Update"},{"issue":"10","key":"1581_CR2","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/j.biocel.2010.06.001","volume":"42","author":"KH Al-Gubory","year":"2010","unstructured":"Al-Gubory KH, Fowler PA, Garrel C. The roles of cellular reactive oxygen species, oxidative stress and antioxidants in pregnancy outcomes. Int J Biochem Cell Biol. 2010;42(10):1634\u201350.","journal-title":"Int J Biochem Cell Biol"},{"key":"1581_CR3","doi-asserted-by":"publisher","first-page":"956792","DOI":"10.1155\/2013\/956792","volume":"2013","author":"B Poljsak","year":"2013","unstructured":"Poljsak B, Suput D, Milisav I. Achieving the balance between ROS and antioxidants: when to use the synthetic antioxidants. Oxid Med Cell Longev. 2013;2013:956792.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"1581_CR4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","volume":"39","author":"M Valko","year":"2007","unstructured":"Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39(1):44\u201384.","journal-title":"Int J Biochem Cell Biol"},{"key":"1581_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ejmech.2015.04.040","volume":"97","author":"AM Pisoschi","year":"2015","unstructured":"Pisoschi AM, Pop A. The role of antioxidants in the chemistry of oxidative stress: a review. Eur J Med Chem. 2015;97:55\u201374.","journal-title":"Eur J Med Chem"},{"issue":"12","key":"1581_CR6","doi-asserted-by":"publisher","first-page":"7966","DOI":"10.1002\/jcp.30468","volume":"236","author":"L Wang","year":"2021","unstructured":"Wang L, Tang J, Wang L, Tan F, Song H, Zhou J, Li F. Oxidative stress in oocyte aging and female reproduction. J Cell Physiol. 2021;236(12):7966\u201383.","journal-title":"J Cell Physiol"},{"issue":"5","key":"1581_CR7","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2018.24","volume":"14","author":"HF Escobar-Morreale","year":"2018","unstructured":"Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270\u201384.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"1581_CR8","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.tem.2019.01.005","volume":"30","author":"Z Merhi","year":"2019","unstructured":"Merhi Z, Kandaraki EA, Diamanti-Kandarakis E. Implications and future perspectives of AGEs in PCOS Pathophysiology. Trends Endocrinol Metab. 2019;30(3):150\u201362.","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"1581_CR9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/cen.13171","volume":"86","author":"R Zhang","year":"2017","unstructured":"Zhang R, Liu H, Bai H, Zhang Y, Liu Q, Guan L, Fan P. Oxidative stress status in chinese women with different clinical phenotypes of polycystic ovary syndrome. Clin Endocrinol (Oxf). 2017;86(1):88\u201396.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"1581_CR10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.rbmo.2011.10.010","volume":"24","author":"P Fan","year":"2012","unstructured":"Fan P, Liu H, Wang Y, Zhang F, Bai H. Apolipoprotein E-containing HDL-associated platelet-activating factor acetylhydrolase activities and malondialdehyde concentrations in patients with PCOS. Reprod Biomed Online. 2012;24(2):197\u2013205.","journal-title":"Reprod Biomed Online"},{"issue":"5","key":"1581_CR11","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.fertnstert.2015.02.024","volume":"103","author":"J Zhang","year":"2015","unstructured":"Zhang J, Zhang Y, Liu H, Bai H, Wang Y, Jiang C, Fan P. Antioxidant properties of high-density lipoproteins are impaired in women with polycystic ovary syndrome. Fertil Steril. 2015;103(5):1346\u201354.","journal-title":"Fertil Steril"},{"issue":"12","key":"1581_CR12","doi-asserted-by":"publisher","first-page":"3560","DOI":"10.1093\/humrep\/des320","volume":"27","author":"F Gonzalez","year":"2012","unstructured":"Gonzalez F, Sia CL, Shepard MK, Rote NS, Minium J. Hyperglycemia-induced oxidative stress is independent of excess abdominal adiposity in normal-weight women with polycystic ovary syndrome. Hum Reprod. 2012;27(12):3560\u20138.","journal-title":"Hum Reprod"},{"issue":"8","key":"1581_CR13","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1210\/jc.2012-1259","volume":"97","author":"F Gonzalez","year":"2012","unstructured":"Gonzalez F, Nair KS, Daniels JK, Basal E, Schimke JM, Blair HE. Hyperandrogenism sensitizes leukocytes to hyperglycemia to promote oxidative stress in lean reproductive-age women. J Clin Endocrinol Metab. 2012;97(8):2836\u201343.","journal-title":"J Clin Endocrinol Metab"},{"key":"1581_CR14","doi-asserted-by":"crossref","unstructured":"Pu Y, Liu Q, Liu H, Bai H, Huang W, Xi M, Fan P. Association between CYP2E1 C-1054T and 96-bp I\/D genetic variations and the risk of polycystic ovary syndrome in chinese women. J Endocrinol Invest 2022.","DOI":"10.1186\/s12884-023-05742-y"},{"issue":"4","key":"1581_CR15","doi-asserted-by":"publisher","first-page":"e13438","DOI":"10.1111\/eci.13438","volume":"51","author":"W Ma","year":"2021","unstructured":"Ma W, Li S, Liu H, Bai H, Liu Q, Hu K, Guan L, Fan P. Myeloperoxidase and CYBA genetic variants in polycystic ovary syndrome. Eur J Clin Invest. 2021;51(4):e13438.","journal-title":"Eur J Clin Invest"},{"key":"1581_CR16","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3389\/fendo.2019.00771","volume":"10","author":"Y Sun","year":"2019","unstructured":"Sun Y, Li S, Liu H, Gong Y, Bai H, Huang W, Liu Q, Guan L, Fan P. Association of GPx1 P198L and CAT C-262T genetic variations with polycystic ovary syndrome in chinese women. Front Endocrinol (Lausanne). 2019;10:771.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"1581_CR17","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s40618-018-0999-5","volume":"42","author":"Q Liu","year":"2019","unstructured":"Liu Q, Liu H, Bai H, Huang W, Zhang R, Tan J, Guan L, Fan P. Association of SOD2 A16V and PON2 S311C polymorphisms with polycystic ovary syndrome in chinese women. J Endocrinol Invest. 2019;42(8):909\u201321.","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"1581_CR18","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1530\/EJE-11-0986","volume":"166","author":"Y Wang","year":"2012","unstructured":"Wang Y, Liu H, Fan P, Bai H, Zhang J, Zhang F. Evidence for association between paraoxonase 1 gene polymorphisms and polycystic ovarian syndrome in southwest Chinese women. Eur J Endocrinol. 2012;166(5):877\u201385.","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"1581_CR19","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1093\/humrep\/deq047","volume":"25","author":"P Fan","year":"2010","unstructured":"Fan P, Liu HW, Wang XS, Zhang F, Song Q, Li Q, Wu HM, Bai H. Identification of the G994T polymorphism in exon 9 of plasma platelet-activating factor acetylhydrolase gene as a risk factor for polycystic ovary syndrome. Hum Reprod. 2010;25(5):1288\u201394.","journal-title":"Hum Reprod"},{"issue":"6","key":"1581_CR20","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1007\/s43032-021-00764-3","volume":"29","author":"C Yang","year":"2022","unstructured":"Yang C, Xi M, Liu H, Bai H, Jiang C, Liu Q, Fan P. Association of polymorphisms of Glutamate Cysteine ligase genes GCLC C-129 T and GCLM C-588 T with risk of polycystic ovary syndrome in chinese women. Reprod Sci. 2022;29(6):1790\u2013800.","journal-title":"Reprod Sci"},{"issue":"R1","key":"1581_CR21","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","volume":"23","author":"G Davey Smith","year":"2014","unstructured":"Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014;23(R1):R89\u201398.","journal-title":"Hum Mol Genet"},{"issue":"7378","key":"1581_CR22","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1136\/bmj.325.7378.1437","volume":"325","author":"GD Smith","year":"2002","unstructured":"Smith GD, Ebrahim S. Data dredging, bias, or confounding. BMJ. 2002;325(7378):1437\u20138.","journal-title":"BMJ"},{"issue":"8","key":"1581_CR23","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/sim.3034","volume":"27","author":"DA Lawlor","year":"2008","unstructured":"Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med. 2008;27(8):1133\u201363.","journal-title":"Stat Med"},{"issue":"2","key":"1581_CR24","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/ije\/dyv108","volume":"44","author":"S Burgess","year":"2015","unstructured":"Burgess S, Timpson NJ, Ebrahim S, Davey Smith G. Mendelian randomization: where are we now and where are we going? Int J Epidemiol. 2015;44(2):379\u201388.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"1581_CR25","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12920-022-01385-8","volume":"15","author":"H Chen","year":"2022","unstructured":"Chen H, Ye R, Guo X. Lack of causal association between heart failure and osteoporosis: a mendelian randomization study. BMC Med Genomics. 2022;15(1):232.","journal-title":"BMC Med Genomics"},{"issue":"1","key":"1581_CR26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12920-022-01366-x","volume":"15","author":"Z Li","year":"2022","unstructured":"Li Z, Chen H, Chen T. Genetic liability to obesity and peptic ulcer disease: a mendelian randomization study. BMC Med Genomics. 2022;15(1):209.","journal-title":"BMC Med Genomics"},{"issue":"3","key":"1581_CR27","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1093\/ije\/dyw127","volume":"45","author":"DA Lawlor","year":"2016","unstructured":"Lawlor DA. Commentary: two-sample mendelian randomization: opportunities and challenges. Int J Epidemiol. 2016;45(3):908\u201315.","journal-title":"Int J Epidemiol"},{"issue":"12","key":"1581_CR28","doi-asserted-by":"publisher","first-page":"e1007813","DOI":"10.1371\/journal.pgen.1007813","volume":"14","author":"F Day","year":"2018","unstructured":"Day F, Karaderi T, Jones MR, Meun C, He C, Drong A, Kraft P, Lin N, Huang H, Broer L, et al. Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria. PLoS Genet. 2018;14(12):e1007813.","journal-title":"PLoS Genet"},{"issue":"2","key":"1581_CR29","doi-asserted-by":"publisher","first-page":"627","DOI":"10.2337\/db20-0800","volume":"70","author":"T Zhu","year":"2021","unstructured":"Zhu T, Cui J, Goodarzi MO. Polycystic ovary syndrome and risk of type 2 diabetes, Coronary Heart Disease, and stroke. Diabetes. 2021;70(2):627\u201337.","journal-title":"Diabetes"},{"key":"1581_CR30","doi-asserted-by":"crossref","unstructured":"Lu Z, Pu C, Zhang Y, Sun Y, Liao Y, Kang Z, Feng X, Yue W. Oxidative stress and Psychiatric Disorders: evidence from the bidirectional mendelian randomization study. Antioxid (Basel) 2022, 11(7).","DOI":"10.3390\/antiox11071386"},{"key":"1581_CR31","doi-asserted-by":"crossref","unstructured":"Uckan K, Demir H, Turan K, Sarikaya E, Demir C. Role of Oxidative Stress in Obese and Nonobese PCOS Patients. Int J Clin Pract 2022, 2022:4579831.","DOI":"10.1155\/2022\/4579831"},{"key":"1581_CR32","doi-asserted-by":"crossref","unstructured":"Yao Q, Zou X, Liu S, Wu H, Shen Q, Kang J. Oxidative Stress as a Contributor to Insulin Resistance in the Skeletal Muscles of Mice with Polycystic Ovary Syndrome. Int J Mol Sci 2022, 23(19).","DOI":"10.3390\/ijms231911384"},{"key":"1581_CR33","doi-asserted-by":"publisher","first-page":"109094","DOI":"10.1016\/j.abb.2021.109094","volume":"715","author":"R Ji","year":"2022","unstructured":"Ji R, Jia FY, Chen X, Wang ZH, Jin WY, Yang J. Salidroside alleviates oxidative stress and apoptosis via AMPK\/Nrf2 pathway in DHT-induced human granulosa cell line KGN. Arch Biochem Biophys. 2022;715:109094.","journal-title":"Arch Biochem Biophys"},{"key":"1581_CR34","unstructured":"Rudnicka E, Duszewska AM, Kucharski M, Tyczynski P, Smolarczyk R. Oxidative stress in polycystic ovary syndrome (PCOS). Reproduction 2022."},{"key":"1581_CR35","doi-asserted-by":"publisher","first-page":"614679","DOI":"10.3389\/fendo.2021.614679","volume":"12","author":"F Duica","year":"2021","unstructured":"Duica F, Danila CA, Boboc AE, Antoniadis P, Condrat CE, Onciul S, Suciu N, Cretoiu SM, Varlas VN, Cretoiu D. Impact of increased oxidative stress on Cardiovascular Diseases in Women with Polycystic Ovary Syndrome. Front Endocrinol (Lausanne). 2021;12:614679.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1581_CR36","doi-asserted-by":"publisher","first-page":"101886","DOI":"10.1016\/j.redox.2021.101886","volume":"41","author":"T Li","year":"2021","unstructured":"Li T, Zhang T, Gao H, Liu R, Gu M, Yang Y, Cui T, Lu Z, Yin C. Tempol ameliorates polycystic ovary syndrome through attenuating intestinal oxidative stress and modulating of gut microbiota composition-serum metabolites interaction. Redox Biol. 2021;41:101886.","journal-title":"Redox Biol"},{"key":"1581_CR37","doi-asserted-by":"crossref","unstructured":"Kamal DAM, Ibrahim SF, Ugusman A, Mokhtar MH. Kelulut Honey ameliorates Oestrus cycle, hormonal profiles, and oxidative stress in Letrozole-Induced polycystic ovary syndrome rats. Antioxid (Basel) 2022, 11(10).","DOI":"10.3390\/antiox11101879"},{"key":"1581_CR38","doi-asserted-by":"crossref","unstructured":"Rudic J, Jakovljevic V, Jovic N, Nikolic M, Sretenovic J, Mitrovic S, Bolevich S, Bolevich S, Mitrovic M, Raicevic S et al. Antioxidative Effects of standardized Aronia melanocarpa extract on Reproductive and metabolic disturbances in a rat model of polycystic ovary syndrome. Antioxid (Basel) 2022, 11(6).","DOI":"10.3390\/antiox11061099"},{"issue":"4","key":"1581_CR39","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s10815-022-02432-0","volume":"39","author":"R Gharaei","year":"2022","unstructured":"Gharaei R, Alyasin A, Mahdavinezhad F, Samadian E, Ashrafnezhad Z, Amidi F. Randomized controlled trial of astaxanthin impacts on antioxidant status and assisted reproductive technology outcomes in women with polycystic ovarian syndrome. J Assist Reprod Genet. 2022;39(4):995\u20131008.","journal-title":"J Assist Reprod Genet"},{"issue":"9","key":"1581_CR40","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1111\/1440-1681.13698","volume":"49","author":"A Karimi","year":"2022","unstructured":"Karimi A, Tutunchi H, Naeini F, Vajdi M, Mobasseri M, Najafipour F. The therapeutic effects and mechanisms of action of resveratrol on polycystic ovary syndrome: a comprehensive systematic review of clinical, animal and in vitro studies. Clin Exp Pharmacol Physiol. 2022;49(9):935\u201349.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"1581_CR41","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3109\/10715762.2015.1006214","volume":"49","author":"SA Kose","year":"2015","unstructured":"Kose SA, Naziroglu M. N-acetyl cysteine reduces oxidative toxicity, apoptosis, and calcium entry through TRPV1 channels in the neutrophils of patients with polycystic ovary syndrome. Free Radic Res. 2015;49(3):338\u201346.","journal-title":"Free Radic Res"},{"key":"1581_CR42","doi-asserted-by":"publisher","first-page":"5185","DOI":"10.2147\/JIR.S379725","volume":"15","author":"BH Marouf","year":"2022","unstructured":"Marouf BH, Ismaeel DO, Hassan AH, Ali OJ. Therapeutic Effects of Silibinin Against Polycystic Ovary Syndrome Induced by Letrozole in rats via its potential anti-inflammatory and anti-oxidant activities. J Inflamm Res. 2022;15:5185\u201399.","journal-title":"J Inflamm Res"},{"issue":"1","key":"1581_CR43","doi-asserted-by":"publisher","first-page":"5770","DOI":"10.1038\/s41598-022-09082-3","volume":"12","author":"G Tefagh","year":"2022","unstructured":"Tefagh G, Payab M, Qorbani M, Sharifi F, Sharifi Y, Ebrahimnegad Shirvani MS, Pourghazi F, Atlasi R, Shadman Z, Rezaei N, et al. Effect of vitamin E supplementation on cardiometabolic risk factors, inflammatory and oxidative markers and hormonal functions in PCOS (polycystic ovary syndrome): a systematic review and meta-analysis. Sci Rep. 2022;12(1):5770.","journal-title":"Sci Rep"},{"issue":"3","key":"1581_CR44","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1007\/s12011-021-02725-y","volume":"200","author":"R Mousavi","year":"2022","unstructured":"Mousavi R, Alizadeh M, Asghari Jafarabadi M, Heidari L, Nikbakht R, Babaahmadi Rezaei H, Karandish M. Effects of Melatonin and\/or magnesium supplementation on biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome: a Randomized, Double-Blind, placebo-controlled trial. Biol Trace Elem Res. 2022;200(3):1010\u20139.","journal-title":"Biol Trace Elem Res"},{"issue":"1","key":"1581_CR45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/ng.732","volume":"43","author":"ZJ Chen","year":"2011","unstructured":"Chen ZJ, Zhao H, He L, Shi Y, Qin Y, Shi Y, Li Z, You L, Zhao J, Liu J, et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet. 2011;43(1):55\u20139.","journal-title":"Nat Genet"},{"issue":"9","key":"1581_CR46","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/ng.2384","volume":"44","author":"Y Shi","year":"2012","unstructured":"Shi Y, Zhao H, Shi Y, Cao Y, Yang D, Li Z, Zhang B, Liang X, Li T, Chen J, et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat Genet. 2012;44(9):1020\u20135.","journal-title":"Nat Genet"},{"key":"1581_CR47","doi-asserted-by":"publisher","first-page":"8464","DOI":"10.1038\/ncomms9464","volume":"6","author":"FR Day","year":"2015","unstructured":"Day FR, Hinds DA, Tung JY, Stolk L, Styrkarsdottir U, Saxena R, Bjonnes A, Broer L, Dunger DB, Halldorsson BV, et al. Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome. Nat Commun. 2015;6:8464.","journal-title":"Nat Commun"},{"key":"1581_CR48","doi-asserted-by":"publisher","first-page":"7502","DOI":"10.1038\/ncomms8502","volume":"6","author":"MG Hayes","year":"2015","unstructured":"Hayes MG, Urbanek M, Ehrmann DA, Armstrong LL, Lee JY, Sisk R, Karaderi T, Barber TM, McCarthy MI, Franks S, et al. Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in european ancestry populations. Nat Commun. 2015;6:7502.","journal-title":"Nat Commun"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01581-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-023-01581-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-023-01581-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T10:04:10Z","timestamp":1687169050000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-023-01581-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,19]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1581"],"URL":"https:\/\/doi.org\/10.1186\/s12920-023-01581-0","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,19]]},"assertion":[{"value":"7 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable. Ethical approval and informed consent for studies included in the analyses were provided in the original publications.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"141"}}